Federal Data Hub › SEC Fails-to-Deliver · JSON
Fails-to-deliver · CUSIP 82937X103
Over the rolling 12-month window, securities of SINO BIOPHARMACEUTICAL AMERICA failed to deliver in the NSCC's Continuous Net Settlement system on 7 settlement days, totaling 4,201 fail shares and peaking at 1,009 shares on 2025-07-29. Persistent or spiking fails-to-deliver can signal delivery stress, naked short selling, or operational settlement problems.
| Settlement date | Fail shares | Price |
|---|---|---|
| 2026-10-02 | 5,130 | $16.28 |
| 2026-10-01 | 4,987 | $14.69 |
| 2026-09-30 | 3,270 | $14.50 |
| 2026-09-29 | 3,270 | $14.38 |
| 2026-09-28 | 1,561 | $14.50 |
| 2025-08-01 | 856 | $18.65 |
| 2025-07-31 | 1,005 | $18.65 |
| 2025-07-30 | 1,005 | $18.65 |
| 2025-07-29 | 1,009 | $18.65 |
| 2025-07-15 | 142 | $16.30 |
| 2025-07-14 | 142 | $16.40 |
| 2025-07-11 | 42 | $15.10 |
A "fail-to-deliver" occurs when a party in a securities trade does not deliver the shares by the settlement date. The SEC publishes twice-monthly files of CNS fails-to-deliver by security. This page aggregates the rolling 12-month window. CUSIP 82937X103 links to this security's other federal filings across the hub.
Source: SEC Fails-to-Deliver Data. License: CC0 1.0.